603998.SSShanghai
Hunan Fangsheng Pharmaceutical Co., Ltd.
¥9.32
ListedDec 5, 2014
SectorHealthcare
IndustryDrug Manufacturers — Specialty & Generic
CountryChina
Employees1868
State-| CityChangsha| AddressNo. 299, Jiayun Road| Phone-
Hunan Fangsheng Pharmaceutical Co., Ltd. engages in research, develops, produces, and sells traditional Chinese medicine industry and chemical pharmaceutical products in China. The company offers pharmaceutical manufacturing; and provides cardiovascular and cerebrovascular drugs, skeletal muscle system drugs, orthopedic drugs, respiratory drugs, pediatric drugs, gynecological drugs, and anti-infective drugs. The company's main products include Xuesetong dispersible tablets, Xuesetong tablets, Garcinia bone-strengthening tablets, Dieda Huoxue capsules, Lysine Vitamin B12 granules, Cefuroxime tablets, Jinying capsules, Pudilan anti-inflammatory tablets, Xiaoer Jingxing cough granules, Ezetimibe tablets, Xuanqi bone-strengthening tablets, Qiangli Loquat Paste (honey-refined), and Qiangli Loquat Dew and others. It also offers other businesses, such as medical services, pharmaceutical commerce, and drug sales. The company was founded in 2002 and is based in Changsha, China.

Key Indicators

Key financial and dividend metrics for this stock.

?
P/E Ratio
14.1
?
Div. Rate
¥0.50
?
Div. Yield
5.05%
?
Payout Ratio
50.00%
?
Max Consec. Div. Years
11 years
?
Longest Consec. Div.
11 years
?
Div. Coverage
100%
?
Div. Stability Rate
0.51
?
Div. Growth Rate
75.00%
?
Score
80

Dividend History

Historical dividend payments by ex-dividend date.

May 29, 2026
¥ 0.1500
Jan 16, 2026
¥ 0.1500
Sep 18, 2025
¥ 0.1500
Jun 9, 2025
¥ 0.2000
Mar 5, 2025
¥ 0.0600
Oct 21, 2024
¥ 0.0500
Jun 11, 2024
¥ 0.2000
Oct 11, 2023
¥ 0.0900
May 10, 2023
¥ 0.2600
Sep 30, 2022
¥ 0.0900
Jun 2, 2022
¥ 0.1500
Jun 11, 2021
¥ 0.0600
Sep 29, 2020
¥ 0.0600
Jun 17, 2020
¥ 0.0600
Jun 18, 2019
¥ 0.0300
Jul 16, 2018
¥ 0.0100
Jul 19, 2017
¥ 0.0100
May 5, 2016
¥ 0.0667
Apr 17, 2015
¥ 0.0308

Peer Companies

Other stocks in the same sector.

The app download will be available in the next version. Stay tuned!